// company-profile

Nuvectis Pharma, Inc.

NVCT
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings77Insiders9
// api This Nuvectis Pharma, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 4 insiders purchased shares. Buying was led by Hoberman Kenneth.

// 90-day insight

Over the last 90 days, Nuvectis Pharma, Inc. insiders bought $0 across 4 transactions with no open-market sales.

  • Most active insider: Hoberman Kenneth with 1 transaction totaling $0.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Nuvectis Pharma, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$32.8M
QoQ change
+21.8%
Reporting period
2026-03-31
#1
VANGUARD CAPITAL MANAGEMENT LLC
CIK 2100119
$5.1M
660K shares
#2
IRIDIAN ASSET MANAGEMENT LLC/CT
CIK 1033427
$4.7M
602K shares
#3
BlackRock, Inc.
CIK 2012383
$4.0M
520K shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 11, 2026Hoberman KennethNVCT
Award
35,000$0.00$0K
Jun 11, 2026Kaplan Matthew L.NVCT
Award
35,000$0.00$0K
Jun 11, 2026Sanchez JuanNVCT
Award
35,000$0.00$0K
Jun 11, 2026Oliviero James F IIINVCT
Award
35,000$0.00$0K
Jan 6, 2026Carson Michael J.NVCT
Award
61,200$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.